Cantex Pharmaceuticals, Inc. 401(k) Plan
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
Sponsored by Cantex Pharmaceuticals, Inc. · Florida · Manufacturing
What the 2023 filing shows
Cantex Pharmaceuticals, Inc. 401(k) Plan holds N/A for 4 participants.
- N/A
- total plan assets (2022 EOY)
- 4
- covered participants
What the Filing Says About Cantex Pharmaceuticals, Inc. 401(k) Plan
Cantex Pharmaceuticals, Inc. 401(k) Plan is a Profit Sharing retirement plan sponsored by Cantex Pharmaceuticals, Inc., headquartered in Florida. As of the 2022 Form 5500 filing, the plan reports N/A in total end-of-year assets and covers 4 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 412035780, and the plan has been effective since 2008-02-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from N/A at the beginning of 2022 to N/A at year-end. Net assets (after liabilities) closed the year at N/A. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | N/A |
| Total Assets (End of Year) | N/A |
| Net Assets (End of Year) | N/A |
| Plan Type | Profit Sharing |
| Employer EIN | 412035780 |
| Plan Effective Date | 2008-02-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (Cantex Pharmaceuticals, Inc.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 4 | N/A |
| 2023 | 1 | 4 | N/A |
| 2024 | 1 | 4 | N/A |
Nearby Profit Sharing Plans in Florida
Peer Profit Sharing plans — same state, same plan type — ranked by total assets.
- Baptist Health South Florida, Inc. 403(b) Employee Retirement Plan $2.3B · 25,214
- University of Miami Retirement Savings Plan $1.7B · 12,683
- Orlando Health Retirement Savings Plan 403b $1.6B · 26,087
- Csx Corporation Capital Builder Plan $1.5B · 20,710
- Brown & Brown, Inc Employee Savings Plan $1.5B · 11,978
Related Data
Guides
Frequently Asked Questions
How much money is in the Cantex Pharmaceuticals, Inc. 401(k) Plan? ▼
What type of plan is Cantex Pharmaceuticals, Inc. 401(k) Plan? ▼
Who sponsors the Cantex Pharmaceuticals, Inc. 401(k) Plan? ▼
How did Cantex Pharmaceuticals, Inc. 401(k) Plan perform in 2022? ▼
Where can I find official filings for Cantex Pharmaceuticals, Inc. 401(k) Plan? ▼
How does Cantex Pharmaceuticals, Inc. 401(k) Plan compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 412035780.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.